Triple E for HCV: Engagement, Education and Eradication of HCV among Patients with Substance Use Disorders

Andrew Talal, MD MPH

Professor and Director, Center for Research and Clinical Care in Liver Disease, University at Buffalo

Clinical Directors Network (CDN), and the Patient Centered Outcomes Research Institute project on Patient-Centered HCV Care via Telemedicine for Individuals on Opiate Substitution Therapy (PCORI Grant # 1507-31640)

1. Review the importance of hepatitis C virus (HCV) screening, diagnosis, and linkage to care 2. Describe new developments in HCV that have eliminated many of the previous barriers to the substance use disorders 3. Develop strategies for the engagement of patients with substance use disorders in HCV care

Tuesday, November 15th, 2016, 12:00 – 1:30 PM EST